NCT07367269 Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy
| NCT ID | NCT07367269 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Artvin Coruh University |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-27 |
| Primary Completion | 2027-01-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-27 with a primary completion date of 2027-01-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Breast cancer patients receiving chemotherapy often experience psychological distress, anxiety, and discomfort during treatment. Non-drug supportive methods may help improve patients' well-being during chemotherapy. This study aims to evaluate whether mandala coloring during outpatient chemotherapy can reduce psychological distress and anxiety and improve comfort in breast cancer patients. Participants will be randomly assigned to either a mandala coloring group or a routine care group. Patients in the intervention group will color mandala patterns for 30 minutes during their chemotherapy session, while the control group will receive routine care only. Psychological distress, anxiety, and comfort levels will be measured before and after the chemotherapy session in both groups. The results of this study may provide evidence for a simple and low-cost supportive intervention to improve the psychological well-being of breast cancer patients during chemotherapy.
Eligibility Criteria
Inclusion Criteria: * Being 18 years of age or older * Having a diagnosis of breast cancer and receiving chemotherapy * Having no communication problems * Having no physical disability that would prevent mandala coloring * Being willing to participate in the study Exclusion Criteria: * not meeting inclusion criteria
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07367269 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07367269 currently recruiting?
Yes, NCT07367269 is actively recruiting participants. Contact the research team at hasdemir52@gmail.com for enrollment information.
Where is the NCT07367269 trial being conducted?
This trial is being conducted at Artvin, Turkey (Türkiye).
Who is sponsoring the NCT07367269 clinical trial?
NCT07367269 is sponsored by Artvin Coruh University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.